Valuation : BioNTech SE

Market Cap 22.43B 26.04B 21.09B 19.26B 36.04B 2,461B 36.16B 249B 96.75B 1,262B 97.8B 95.65B 4,070B P/E 2026 *
-15.8x
P/E 2027 * -17.3x
Enterprise Value 11.06B 12.84B 10.4B 9.5B 17.77B 1,214B 17.83B 123B 47.71B 622B 48.23B 47.17B 2,007B EV / Sales 2026 *
6.12x
EV / Sales 2027 * 6.84x
Free-Float
96.06%
Yield 2026 *
-
Yield 2027 * -
1 day+0.86%
1 week+1.65%
Current month+2.12%
1 month+13.59%
3 months+15.82%
6 months-0.04%
Current year+8.99%
1 week 100.3
Extreme 100.295
105.46
1 month 89.7
Extreme 89.7
120.33
Current year 79.52
Extreme 79.52
124
1 year 79.52
Extreme 79.52
124
3 years 76.53
Extreme 76.5301
131.49
5 years 76.53
Extreme 76.5301
374.85
10 years 12.52
Extreme 12.525
464
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 01/01/2018
Chief Executive Officer 61 02/06/2008
Director of Finance/CFO - 01/07/2025
Director TitleAgeSince
Chairman 56 02/06/2008
Director/Board Member 69 02/06/2008
Director/Board Member 65 01/01/2018
Date Insider Type Main position Quantity % Market Cap. Importance
12/5/26 Free

Chief Operating Officer

22,655 0.0094%
12/5/26 Free

Chief Financial Officer

33,982 0.0141%
12/5/26 Free

Head of Human Resources

18,879 0.0078%
Change 5-day change 1-year change 3-year change Capi.($)
+0.86%+1.65%+0.25%-14.78% 26.06B
-1.79%-2.27%+50.90%+89.03% 67.98B
-2.06%-0.18%+41.53%+88.17% 64.94B
-0.31%+6.54%-11.39%+457.82% 27.58B
-3.00%-2.90%+39.40%+9.41% 25.74B
-1.46%+0.42%+24.07%-18.70% 20.09B
-2.96%-15.21%+210.71%+370.84% 17.16B
-1.49%-4.88%-0.41%+530.26% 14.92B
-0.20%+8.37%+57.87%+159.50% 14.62B
+2.77%+28.22%-26.03%+980.06% 14.04B
Average -0.96%+3.05%+38.69%+265.16% 29.31B
Weighted average by Cap. -1.31%+1.52%+39.02%+185.08%

Financials

2026 *2027 *
Net sales 1.81B 2.1B 1.7B 1.55B 2.9B 198B 2.91B 20.07B 7.79B 102B 7.88B 7.7B 328B 1.81B 2.11B 1.7B 1.56B 2.91B 199B 2.92B 20.14B 7.82B 102B 7.91B 7.73B 329B
Net income -1.38B -1.6B -1.3B -1.18B -2.21B -151B -2.22B -15.31B -5.94B -77.52B -6.01B -5.88B -250B -1.31B -1.52B -1.23B -1.12B -2.1B -144B -2.11B -14.54B -5.65B -73.63B -5.71B -5.58B -237B
Net Debt -11.37B -13.2B -10.69B -9.76B -18.27B -1,247B -18.33B -126B -49.04B -640B -49.57B -48.48B -2,063B -10.03B -11.65B -9.43B -8.61B -16.12B -1,101B -16.17B -111B -43.27B -564B -43.74B -42.78B -1,820B
Logo BioNTech SE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Employees
7,807
Date Price Change Volume
04/09/26 US$103.76 +0.86% 626,059
03/09/26 US$102.88 -0.90% 1,180,896
02/09/26 US$103.81 +1.83% 753,654
01/09/26 US$101.95 +0.33% 1,040,116
31/08/26 US$101.61 -0.46% 1,089,897
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
89.29EUR
Average target price
103.52EUR
Spread / Average Target
+15.94%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BNTX Stock